Estradiol phosphate: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
[[Category:Hormone therapy]] | [[Category:Hormone therapy]] | ||
[[Category:Transgender and medicine]] | [[Category:Transgender and medicine]] | ||
== Estradiol_phosphate == | |||
<gallery> | |||
File:Estradiol_17-phosphate.svg|Estradiol 17-phosphate | |||
</gallery> | |||
Latest revision as of 20:46, 16 March 2025
Estradiol phosphate is a steroid and estrogen that is used in hormone therapy. It is a prodrug of estradiol, and when administered into the body, it is converted into estradiol. Estradiol phosphate is used in the treatment of menopausal symptoms, hormone-sensitive cancers, and in hormone replacement therapy for transgender women.
Pharmacology[edit]
Estradiol phosphate is a prodrug of estradiol, meaning it is metabolized into estradiol in the body. It is administered via intramuscular injection, and has a longer duration of action compared to estradiol. This is due to the slow release of estradiol from the injection site, and the slow conversion of estradiol phosphate into estradiol.
Medical uses[edit]
Estradiol phosphate is used in the treatment of menopausal symptoms such as hot flashes and vaginal dryness. It is also used in the treatment of hormone-sensitive cancers such as breast cancer and prostate cancer. In addition, estradiol phosphate is used in hormone replacement therapy for transgender women, to help them develop secondary sexual characteristics.
Side effects[edit]
Like all estrogens, estradiol phosphate can have side effects. These can include nausea, breast tenderness, and an increased risk of blood clots. Long-term use of estradiol phosphate can also increase the risk of endometrial cancer and breast cancer.
See also[edit]
Estradiol_phosphate[edit]
-
Estradiol 17-phosphate

